ARGX
argenx NV ADR
NASDAQ: ARGX · HEALTHCARE · BIOTECHNOLOGY
$781.72
+0.73% today
Updated 2026-04-30
Market cap
$48.85B
P/E ratio
40.03
P/S ratio
11.53x
EPS (TTM)
$19.53
Dividend yield
—
52W range
$510 – $935
Volume
0.3M
WallStSmart proprietary scores
61
out of 100
Grade: C+
Hold
Investment rating
7.3
Growth
B+6.0
Quality
B9.0
Profitability
A+6.7
Valuation
B3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$1,036.80
+32.63%
12-Month target
$585.53
-25.10%
Intrinsic (DCF)
$2,119.32
Margin of safety
+60.62%
6 Strong Buy15 Buy3 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 30.50% — above average
+ ROE 20.20% — strong efficiency
+ Free cash flow $406.90M — positive
+ Revenue growth 73.00% QoQ
+ 60.62% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- P/E 40.03x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $410.75M | $1.23B | $2.19B | $4.16B | $4.24B | $6.1B |
| Net income | $-709.59M | $-295.05M | $833.04M | $1.30B | $874.92M | — |
| EPS | — | — | — | — | $19.53 | $27.90 |
| Free cash flow | $-966.63M | $-464.14M | $-151.05M | $844.30M | $406.90M | — |
| Profit margin | -172.76% | -24.06% | 38.03% | 31.12% | 30.50% | — |
Peer comparison
Smart narrative
argenx NV ADR trades at $781.72. representing a P/E of 40.03x trailing earnings. Our Smart Value Score of 61/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $4.24B. with profit margins at 30.50%. Our DCF model estimates intrinsic value at $2,119.32.
Frequently asked questions
What is argenx NV ADR's stock price?
argenx NV ADR (ARGX) trades at $781.72.
Is argenx NV ADR overvalued?
Smart Value Score 61/100 (Grade C+, Hold). DCF value $2,119.32.
What is the price target of argenx NV ADR (ARGX)?
The analyst target price is $1,036.80, representing +32.6% upside from the current price of $781.72.
What is the intrinsic value of argenx NV ADR (ARGX)?
Based on our DCF model, intrinsic value is $2,119.32, a +60.6% margin of safety versus $781.72.
What is the future stock price of ARGX by 2030?
Our research-backed model estimates argenx NV ADR could reach $3,358.89 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is argenx NV ADR's revenue?
TTM revenue is $4.24B.
Piotroski F-Score?
3/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio11.53x
ROE20.20%
Beta-0.09
50D MA$760.30
200D MA$779.33
Shares out0.06B
Float0.06B
Short ratio—
Avg volume0.3M
Performance
1 week-1.51%
1 month+6.27%
3 months-8.46%
YTD-7.72%
1 year—
3 years—
5 years—